{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:20:35Z","timestamp":1782296435356,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T00:00:00Z","timestamp":1708214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00204-023-03674-2","type":"journal-article","created":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T19:02:11Z","timestamp":1708282931000},"page":"1095-1110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro and in vivo metabolic activation and hepatotoxicity of chlorzoxazone mediated by CYP3A"],"prefix":"10.1007","volume":"98","author":[{"given":"Chen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2147","authenticated-orcid":false,"given":"Jiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,18]]},"reference":[{"key":"3674_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2018.02.020","volume":"153","author":"T Ahmad","year":"2018","unstructured":"Ahmad T, Valentovic MA, Rankin GO (2018) Effects of cytochrome P450 single nucleotide polymorphisms on methadone metabolism and pharmacodynamics. Biochem Pharmacol 153:196\u2013204","journal-title":"Biochem Pharmacol"},{"key":"3674_CR2","doi-asserted-by":"crossref","unstructured":"Aronson JK (2016) chlorzoxazone. In: Aronson JK (ed) Meyler's Side Effects of Drugs. Elsevier Science, Netherlands, pp:279","DOI":"10.1016\/B978-0-444-53717-1.00487-X"},{"key":"3674_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4161\/oxim.3.4.13246","volume":"3","author":"SM Attia","year":"2010","unstructured":"Attia SM (2010) Deleterious Effects of Reactive Metabolites. Oxid Med Cell Longev 3:238\u2013253","journal-title":"Oxid Med Cell Longev"},{"key":"3674_CR4","first-page":"218","volume":"28","author":"SL Born","year":"2000","unstructured":"Born SL, Hu JK, Lehman-McKeeman LD (2000) O-Hydroxyphenylacetaldehyde is a hepatotoxic metabolite of coumarin. Drug Metab Dispos 28:218\u2013223","journal-title":"Drug Metab Dispos"},{"key":"3674_CR5","first-page":"440","volume":"34","author":"GP Carlson","year":"2011","unstructured":"Carlson GP (2011) Hepatotoxicity and pneumotoxicity of styrene and its metabolites in glutathione S-transferase-deficient mice. Drug Metab Dispos 34:440\u2013444","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"3674_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/tx00036a015","volume":"6","author":"V Carriere","year":"1993","unstructured":"Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, Berthou F (1993) Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6(6):852\u2013857","journal-title":"Chem Res Toxicol"},{"key":"3674_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","volume":"21","author":"M Chen","year":"2016","unstructured":"Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W (2016) DILIrank: The largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 21:648\u2013653","journal-title":"Drug Discov Today"},{"issue":"1","key":"3674_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","volume":"30","author":"T Cho","year":"2017","unstructured":"Cho T, Uetrecht J (2017) How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction. Chem Res Toxicol 30(1):295\u2013314","journal-title":"Chem Res Toxicol"},{"key":"3674_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/jps.2600720905","volume":"72","author":"RK Desiraju","year":"1983","unstructured":"Desiraju RK, Renzi NL, Nayak RK, Ng KT (1983) Pharmacokinetics of chlorzoxazone in humans. J Pharm Sci-US 72:991\u2013994","journal-title":"J Pharm Sci-US"},{"key":"3674_CR10","first-page":"369","volume":"55","author":"EF Domino","year":"1974","unstructured":"Domino EF (1974) Centrally acting skeletal-muscle relaxants. Arch Phys Med Rehab 55:369\u2013373","journal-title":"Arch Phys Med Rehab"},{"key":"3674_CR11","unstructured":"FDA (2022) In Vitro Drug Interaction Studies\u2014Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry. Official website of the United States Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers. Accessed 6 July 2022."},{"issue":"4","key":"3674_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0021-9258(19)45624-X","volume":"247","author":"JE Gielen","year":"1972","unstructured":"Gielen JE, Goujon FM, Nebert DW (1972) Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. J Biol Chem 247(4):1125\u20131137","journal-title":"J Biol Chem"},{"issue":"1","key":"3674_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0003-9861(02)00415-0","volume":"409","author":"FP Guengerich","year":"2003","unstructured":"Guengerich FP (2003) Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions. Arch of Biochem Biophys 409(1):59\u201371","journal-title":"Arch of Biochem Biophys"},{"key":"3674_CR14","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1021\/ja00300a033","volume":"107","author":"DM Jerina","year":"1985","unstructured":"Jerina DM, Daly JW, Gouterman M, Spangler D, Loew G (1985) Cytochrome-P450 mediated aromatic oxidation-a theoretical-study. J Am Chem Soc 107:4273\u20134279","journal-title":"J Am Chem Soc"},{"issue":"4","key":"3674_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/em.21912","volume":"56","author":"H Jiang","year":"2015","unstructured":"Jiang H, Lai YM, Hu KQ, Chen DX, Liu BX, Liu YG (2015) Genotoxicity of 1-methylpyrene and 1-hydroxymethylpyrene in Chinese hamster V79-derived cells expressing both human CYP2E1 and SULT1A1. Environ Mol Mutagen 56(4):404\u2013411","journal-title":"Environ Mol Mutagen"},{"key":"3674_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1389200054021799","volume":"6","author":"AS Kalgutkar","year":"2005","unstructured":"Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR, Mutlib AE, Dalvie DK, Lee JS, Nakai Y (2005) A Comprehensive Listing of Bioactivation Pathways of Organic Functional Groups. Curr Drug Metab 6:161\u2013225","journal-title":"Curr Drug Metab"},{"key":"3674_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0009-9236(95)90227-9","volume":"57","author":"RB Kim","year":"1995","unstructured":"Kim RB, O\u2019shea D, Wilkinson GR (1995) Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin Pharmacol Ther 57:645\u2013665","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3674_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/03602532.2011.605791","volume":"44","author":"L Leung","year":"2012","unstructured":"Leung L, Kalgutkar AS, Obach RS (2012) Metabolic activation in drug-induced liver injury. Drug Metab Rev 44(1):18\u201333","journal-title":"Drug Metab Rev"},{"key":"3674_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1124\/dmd.106.014100","volume":"35","author":"G Lin","year":"2007","unstructured":"Lin G, Tang J, Liu X, Jiang Y, Zheng J (2007) Deacetylclivorine: A gender-selective metabolite formed in female SD rat liver microsome. Drug Metab Dispos 35:607\u2013613","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"3674_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00008571-199906000-00013","volume":"9","author":"D Lucas","year":"1999","unstructured":"Lucas D, Ferrara R, Gonzalez E, Bodenez P, Albores A, Manno M, Berthou F (1999) Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans. Pharmacogenetics 9(3):377\u2013388","journal-title":"Pharmacogenetics"},{"key":"3674_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF01245348","volume":"89","author":"BA McMillen","year":"1992","unstructured":"McMillen BA, Williams HL, Lehmann H, Shepard PD (1992) On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine and HA-966. J Neural Transm 89:11\u201325","journal-title":"J Neural Transm"},{"key":"3674_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2020.123377","volume":"401","author":"F Menger","year":"2021","unstructured":"Menger F, Ahrens L, Wiberg K, Gago-Ferrero P (2021) Suspect screening based on market data of polar halogenated micropollutants in river water affected by wastewater. J Hazard Mater 401:123377","journal-title":"J Hazard Mater"},{"key":"3674_CR23","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1021\/tx700446u","volume":"21","author":"C Morisseau","year":"2008","unstructured":"Morisseau C, Newman JW, Wheelock CE, Hill T III, Morin D, Buckpitt AR, Hammock BD (2008) Development of metabolically stable inhibitors of mammalian microsomal epoxide hydrolase. Chem Res Toxicol 21:951\u2013957","journal-title":"Chem Res Toxicol"},{"issue":"65","key":"3674_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/newbio236107a0","volume":"236","author":"DW Nebert","year":"1972","unstructured":"Nebert DW, Goujon FM, Gielen JE (1972) Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nat New Biol 236(65):107\u2013110","journal-title":"Nat New Biol"},{"issue":"5","key":"3674_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/00498257309151525","volume":"3","author":"F Oesch","year":"1973","unstructured":"Oesch F (1973) Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3(5):305\u2013340","journal-title":"Xenobiotica"},{"issue":"3","key":"3674_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00008571-199506000-00002","volume":"5","author":"S Ono","year":"1995","unstructured":"Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T, Gonzalez FJ (1995) Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5(3):143\u2013150","journal-title":"Pharmacogenetics"},{"key":"3674_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/B978-0-443-06651-1.50021-6","volume-title":"Essentials of Pain Medicine and Regional Anesthesia","author":"MD Onur Melen","year":"2005","unstructured":"Onur Melen MD (2005) Muscle Relaxants. In: Honorio TB, Srinivasa NR, Robert EM, Spencer SL, Scott MF (eds) Essentials of Pain Medicine and Regional Anesthesia, 2nd edn. Churchill Livingstone, London, pp 159\u2013165","edition":"2"},{"key":"3674_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev.pharmtox.45.120403.100058","volume":"45","author":"BK Park","year":"2005","unstructured":"Park BK, Kitteringham NR, Maggs JL, Pirmohamed M, Williams DP (2005) The role of metabolic activation in drug-induced hepatotoxicity. Annu Rev Pharmacol Toxicol 45:177\u2013202","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3674_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbi.2010.09.011","volume":"192","author":"BK Park","year":"2011","unstructured":"Park BK, Laverty H, Srivastava A, Antoine DJ, Naisbitt D, Williams DP (2011) Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem Biol Interact 192:30\u201336","journal-title":"Chem Biol Interact"},{"key":"3674_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1021\/tx00018a012","volume":"3","author":"R Peter","year":"1990","unstructured":"Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 3:566\u2013573","journal-title":"Chem Res Toxicol"},{"key":"3674_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/jat.2892","volume":"34","author":"S Qiang","year":"2014","unstructured":"Qiang S, Greenhaw J, Salminen WF (2014) Inhibition of cytochrome P450s enhances (+)-usnic acid cytotoxicity in primary cultured rat hepatocytes. J Appl Toxicol 34:835\u2013840","journal-title":"J Appl Toxicol"},{"issue":"3","key":"3674_CR32","first-page":"484","volume":"10","author":"JR Robinson","year":"1974","unstructured":"Robinson JR, Nebert DW (1974) Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism. Mol Pharmacol 10(3):484\u2013493","journal-title":"Mol Pharmacol"},{"key":"3674_CR33","first-page":"75","volume":"129","author":"AP Roszkowski","year":"1960","unstructured":"Roszkowski AP (1960) A pharmacological comparison of therapeutically useful centrally acting skeletal muscle relaxants. J Pharmacol Exp Ther 129:75\u201381","journal-title":"J Pharmacol Exp Ther"},{"issue":"64","key":"3674_CR34","volume":"64","author":"L Shen","year":"2012","unstructured":"Shen L, Hillebrand A, Wang DQH, Liu M (2012) Isolation and Primary Culture of Rat Hepatic Cells. JOVE-J vis Exp 64(64):e3917","journal-title":"JOVE-J vis Exp"},{"key":"3674_CR35","doi-asserted-by":"crossref","unstructured":"Steven DW (2009) Skeletal Muscle Relaxants. In: Steven DW (ed) Pain Review. Saunders [Imprint], Elsevier: Health Sciences Division, Philadelphia, pp 651\u2013656","DOI":"10.1016\/B978-1-4160-5893-9.00347-6"},{"key":"3674_CR36","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/B978-0-12-386454-3.00285-2","volume-title":"Encyclopedia of Toxicology","author":"KN Thakore","year":"2014","unstructured":"Thakore KN, Mehendale HM (2014) Chlorzoxazone. In: Wexler P (ed) Encyclopedia of Toxicology, 3rd edn. Academic Press, New York, pp 938\u2013939","edition":"3"},{"issue":"9","key":"3674_CR37","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1021\/bi00680a033","volume":"14","author":"JE Tomaszewski","year":"1975","unstructured":"Tomaszewski JE, Jerina DM, Daly JW (1975) Deuterium isotope effects during formation of phenols by hepatic monoxygenases. Evidence for an alternative to the arene oxide pathway. Biochemistry 14(9):2024\u20132031","journal-title":"Biochemistry"},{"issue":"2","key":"3674_CR38","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0003-9861(76)90223-X","volume":"176","author":"JE Tomaszewski","year":"1976","unstructured":"Tomaszewski JE, Jerina DM, Levin W, Conney AH (1976) A highly sensitive radiometric assay for zoxazolamine hydroxylation by liver microsomal cytochrome P-450 and P-448: Properties of the membrane-bound and purified reconstituted system. Arch Biochem Biophys 176(2):788\u2013798","journal-title":"Arch Biochem Biophys"},{"key":"3674_CR39","first-page":"759","volume":"32","author":"R Twele","year":"1982","unstructured":"Twele R, Spiteller G (1982) Identification of chlorzoxazone metabolites in human urine (author\u2019s transl). Arzneimittelforschung 32:759\u2013763","journal-title":"Arzneimittelforschung"},{"key":"3674_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1124\/pr.113.007450","volume":"65","author":"J Uetrecht","year":"2013","unstructured":"Uetrecht J, Naisbitt DJ (2013) Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev 65:779\u2013808","journal-title":"Pharmacol Rev"},{"key":"3674_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1124\/dmd.115.066803","volume":"44","author":"K Wang","year":"2016","unstructured":"Wang K, Wang H, Peng Y, Zheng J (2016) Identification of epoxide-derived metabolite(s) of benzbromarone. Drug Metab Dispos 44:607\u2013615","journal-title":"Drug Metab Dispos"},{"key":"3674_CR42","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1124\/dmd.117.077818","volume":"45","author":"H Wang","year":"2017","unstructured":"Wang H, Peng Y, Zhang T, Lan Q, Zhao H, Wang W, Zhao Y, Wang X, Pang J, Wang S, Zheng J (2017) Metabolic epoxidation is a critical step for the development of benzbromarone-induced hepatotoxicity. Drug Metab Dispos 45:1354\u20131363","journal-title":"Drug Metab Dispos"},{"key":"3674_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jchromb.2016.05.049","volume":"1027","author":"L Witt","year":"2016","unstructured":"Witt L, Suzuki Y, Hohmann N, Mikus G, Haefeli WE, Burhenne JU (2016) ltrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing. J Chromatogr B 1027:207\u2013213","journal-title":"J Chromatogr B"},{"issue":"7","key":"3674_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1023\/A:1015976131643","volume":"5","author":"M Yasuhara","year":"1988","unstructured":"Yasuhara M, Levy G (1988) Pharmacodynamics of zoxazolamine and chlorzoxazone in rats. Pharm Res 5(7):401\u2013407","journal-title":"Pharm Res"},{"issue":"3","key":"3674_CR45","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1530-0277.1998.tb04307.x","volume":"22","author":"A Zerilli","year":"1998","unstructured":"Zerilli A, Lucas D, Dreano Y, Picart D, Berthou F (1998) Effect of pyrazole and dexamethasone administration on cytochrome P450 2E1 and 3A isoforms in rat liver and kidney: lack of specificity of p-nitrophenol as a substrate of P450 2E1. Alcohol Clin Exp Res 22(3):652\u2013657","journal-title":"Alcohol Clin Exp Res"},{"key":"3674_CR46","first-page":"544","volume-title":"Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver","author":"HJ Zimmerman","year":"1999","unstructured":"Zimmerman HJ (1999) Muscle spasmolytics. In: Zimmerman HJ (ed) Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver, 2nd edn. Lippincott, Philadelphia, pp 544\u2013545","edition":"2"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03674-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T06:07:03Z","timestamp":1710569223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03674-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,18]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["3674"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03674-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,18]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}